CPT code 22900 represents the surgical excision of an abnormal mass within the muscle layer beneath the abdominal wall, with the specimen submitted for laboratory analysis and measuring less than 5 cm. This procedure is clinically significant because it addresses potential benign or malignant soft-tissue lesions that require both therapeutic removal and diagnostic evaluation. Nationally, the code is used across inpatient and outpatient surgical settings and has implications for surgical practice patterns, pathology utilization, and episode-of-care costing.

Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a clinical and billing context for using CPT code 22900, including the typical sites of service, common service line placement, and how the code fits within surgical management of abdominal wall masses. The publication outlines benchmark considerations, payer coverage patterns where available, and policy implications affecting billing and documentation for excision of intramuscular abdominal wall lesions.

The report is intended for clinicians, coding professionals, and policy analysts seeking a concise reference on CPT code 22900, its clinical scope, and the administrative considerations that commonly accompany surgical excision of small intramuscular abdominal masses.